Cargando…
Sodium Butyrate Enhances Curcuminoids Permeability through the Blood-Brain Barrier, Restores Wnt/β-Catenin Pathway Antagonists Gene Expression and Reduces the Viability of Glioblastoma Cells
Glioblastoma (GBM) is an extremely aggressive brain tumor awaiting novel, efficient, and minimally toxic treatment. Curcuminoids (CCM), polyphenols from Curcuma longa, and sodium butyrate (NaBu), a histone deacetylase inhibitor naturally occurring in the human body, await elucidation as potential an...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540692/ https://www.ncbi.nlm.nih.gov/pubmed/34681943 http://dx.doi.org/10.3390/ijms222011285 |
_version_ | 1784589048546852864 |
---|---|
author | Majchrzak-Celińska, Aleksandra Kleszcz, Robert Stasiłowicz-Krzemień, Anna Cielecka-Piontek, Judyta |
author_facet | Majchrzak-Celińska, Aleksandra Kleszcz, Robert Stasiłowicz-Krzemień, Anna Cielecka-Piontek, Judyta |
author_sort | Majchrzak-Celińska, Aleksandra |
collection | PubMed |
description | Glioblastoma (GBM) is an extremely aggressive brain tumor awaiting novel, efficient, and minimally toxic treatment. Curcuminoids (CCM), polyphenols from Curcuma longa, and sodium butyrate (NaBu), a histone deacetylase inhibitor naturally occurring in the human body, await elucidation as potential anti-GBM agents. Thus, the aim of this study was to analyze CCM and NaBu both separately and as a combination treatment using three GBM cell lines. MTT was used for cytotoxicity evaluation, and the combination index was calculated for synergism prediction. Cell cycle, apoptosis, and reactive oxygen species (ROS) generation were analyzed using flow cytometry. DNA methylation was verified by MS-HRM and mRNA expression by qPCR. The permeability through the blood-brain barrier (BBB) and through the nasal cavity was evaluated using PAMPA model. The results of this study indicate that CCM and NaBu synergistically reduce the viability of GBM cells inducing apoptosis and cell cycle arrest. These effects are mediated via ROS generation and changes in gene expression, including upregulation of Wnt/β-catenin pathway antagonists, SFRP1, and RUNX3, and downregulation of UHRF1, the key epigenetic regulator. Moreover, NaBu ameliorated CCM permeability through the BBB and the nasal cavity. We conclude that CCM and NaBu are promising agents with anti-GBM properties. |
format | Online Article Text |
id | pubmed-8540692 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85406922021-10-24 Sodium Butyrate Enhances Curcuminoids Permeability through the Blood-Brain Barrier, Restores Wnt/β-Catenin Pathway Antagonists Gene Expression and Reduces the Viability of Glioblastoma Cells Majchrzak-Celińska, Aleksandra Kleszcz, Robert Stasiłowicz-Krzemień, Anna Cielecka-Piontek, Judyta Int J Mol Sci Article Glioblastoma (GBM) is an extremely aggressive brain tumor awaiting novel, efficient, and minimally toxic treatment. Curcuminoids (CCM), polyphenols from Curcuma longa, and sodium butyrate (NaBu), a histone deacetylase inhibitor naturally occurring in the human body, await elucidation as potential anti-GBM agents. Thus, the aim of this study was to analyze CCM and NaBu both separately and as a combination treatment using three GBM cell lines. MTT was used for cytotoxicity evaluation, and the combination index was calculated for synergism prediction. Cell cycle, apoptosis, and reactive oxygen species (ROS) generation were analyzed using flow cytometry. DNA methylation was verified by MS-HRM and mRNA expression by qPCR. The permeability through the blood-brain barrier (BBB) and through the nasal cavity was evaluated using PAMPA model. The results of this study indicate that CCM and NaBu synergistically reduce the viability of GBM cells inducing apoptosis and cell cycle arrest. These effects are mediated via ROS generation and changes in gene expression, including upregulation of Wnt/β-catenin pathway antagonists, SFRP1, and RUNX3, and downregulation of UHRF1, the key epigenetic regulator. Moreover, NaBu ameliorated CCM permeability through the BBB and the nasal cavity. We conclude that CCM and NaBu are promising agents with anti-GBM properties. MDPI 2021-10-19 /pmc/articles/PMC8540692/ /pubmed/34681943 http://dx.doi.org/10.3390/ijms222011285 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Majchrzak-Celińska, Aleksandra Kleszcz, Robert Stasiłowicz-Krzemień, Anna Cielecka-Piontek, Judyta Sodium Butyrate Enhances Curcuminoids Permeability through the Blood-Brain Barrier, Restores Wnt/β-Catenin Pathway Antagonists Gene Expression and Reduces the Viability of Glioblastoma Cells |
title | Sodium Butyrate Enhances Curcuminoids Permeability through the Blood-Brain Barrier, Restores Wnt/β-Catenin Pathway Antagonists Gene Expression and Reduces the Viability of Glioblastoma Cells |
title_full | Sodium Butyrate Enhances Curcuminoids Permeability through the Blood-Brain Barrier, Restores Wnt/β-Catenin Pathway Antagonists Gene Expression and Reduces the Viability of Glioblastoma Cells |
title_fullStr | Sodium Butyrate Enhances Curcuminoids Permeability through the Blood-Brain Barrier, Restores Wnt/β-Catenin Pathway Antagonists Gene Expression and Reduces the Viability of Glioblastoma Cells |
title_full_unstemmed | Sodium Butyrate Enhances Curcuminoids Permeability through the Blood-Brain Barrier, Restores Wnt/β-Catenin Pathway Antagonists Gene Expression and Reduces the Viability of Glioblastoma Cells |
title_short | Sodium Butyrate Enhances Curcuminoids Permeability through the Blood-Brain Barrier, Restores Wnt/β-Catenin Pathway Antagonists Gene Expression and Reduces the Viability of Glioblastoma Cells |
title_sort | sodium butyrate enhances curcuminoids permeability through the blood-brain barrier, restores wnt/β-catenin pathway antagonists gene expression and reduces the viability of glioblastoma cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540692/ https://www.ncbi.nlm.nih.gov/pubmed/34681943 http://dx.doi.org/10.3390/ijms222011285 |
work_keys_str_mv | AT majchrzakcelinskaaleksandra sodiumbutyrateenhancescurcuminoidspermeabilitythroughthebloodbrainbarrierrestoreswntbcateninpathwayantagonistsgeneexpressionandreducestheviabilityofglioblastomacells AT kleszczrobert sodiumbutyrateenhancescurcuminoidspermeabilitythroughthebloodbrainbarrierrestoreswntbcateninpathwayantagonistsgeneexpressionandreducestheviabilityofglioblastomacells AT stasiłowiczkrzemienanna sodiumbutyrateenhancescurcuminoidspermeabilitythroughthebloodbrainbarrierrestoreswntbcateninpathwayantagonistsgeneexpressionandreducestheviabilityofglioblastomacells AT cieleckapiontekjudyta sodiumbutyrateenhancescurcuminoidspermeabilitythroughthebloodbrainbarrierrestoreswntbcateninpathwayantagonistsgeneexpressionandreducestheviabilityofglioblastomacells |